Table 1.
Demographics of study cohorts and sampling time points.
| Vaccinees (3 mRNA vaccinations) | WT convalescent + 3 mRNA vaccinations | WT primary infection | Omicron BA1 primary infection | Omicron BA2 primary infection | Omicron breakthrough infections | |
|---|---|---|---|---|---|---|
| n | 15 | 9 | 11 | 22 | 21 | 43 |
| Median age in years [range] | 39 [23-59] | 42 [27-60] | 33 [19-52] | 42 [4-64] | 45 [24 - 81] | 40 [18 - 76] |
| Male sex (% of N) | 2 (13) | 3 (33) | 9 (82) | 7 (32) | 10 (48) | 16 (37) |
| Samples in dpoa/dpvb [range] | / | / | / | 35 [16-79] | 31 [10 - 90] | 27 [10 - 72] |
| 1st samples in dpoa/dpvb [range] | 26 [15-38] | 24 [14-28] | 18 [10-25] | / | / | / |
| Follow-up samples in dpoa/dpvb [range] | 106 [79-133] | / | 215 [168-272] | / | / | / |
a dpo, days post onset of symptoms; b dpv, days post vaccination.